REQUEST A DEMO
Total
USD $0.00
Search more companies

"Axfarm" Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: "Axfarm" Sp. z o.o. Profile Updated: March 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Axfarm Sp. z o.o is a pharmaceutical company operating in Poland and abroad. They create and manufacture their own brands aimed at pharmacies, medical offices, and other pharmaceutical wholesale. Axfarm's products include medical devices such as Otovent for middle ear pressure balance, Cerumex drops and spray for dissolving wax, GardVit A+E for mucosa regeneration, Ringosol for nasal moisturizing, Voskolix for ear cleaning, and AloeNasin for nasal moisturizing. They also offer single-use laryngological patterns. The company operates in accordance with ISO:13485 standards.

Headquarters
Ul. Chodkiewicza 73/26
Bydgoszcz; Kujawsko-Pomorskie; Postal Code: 85-667

Contact Details: Purchase the "Axfarm" Sp. z o.o. report to view the information.

Website: http://www.axfarm.com.pl

Basic Information
Total Employees:
Purchase the "Axfarm" Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the "Axfarm" Sp. z o.o. report to view the information.
Registered Capital:
Purchase the "Axfarm" Sp. z o.o. report to view the information.
Incorporation Date:
July 15, 2003
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
83%
Purchase this report to view the information.
17%
Company Performance
Financial values in the chart are available after "Axfarm" Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
6.65%
Total operating revenue
7.91%
Net Profit (Loss) for the Period
-15.38%
Total assets
3.49%
Total equity
15.56%
Net Profit Margin
-2.77%
Return on Equity (ROE)
-5.67%
Quick Ratio
6.76%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?